Sugi Predict

Sugi Predict / Compounds / SCHEMBL14937997

SCHEMBL14937997

SCHEMBL14937997

COc1cccc(-c2cn(C(=O)N(C)C3CCN(S(C)(=O)=O)CC3)cn2)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 6/20 0.53
▸ FAAH O00519 1/20 0.51
▸ CES2 O00748 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.46
▸ CACNA2D1 P54289 1/20 0.43
▸ MCHR1 Q99705 1/20 0.43
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ HTR3A P46098 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HPGDS O60760 1/20 0.39
▸ NEK2 P51955 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TAF1 P21675 1/20 0.39
▸ CECR2 Q9BXF3 1/20 0.39
▸ BRD9 Q9H8M2 1/20 0.39
▸ CCR5 P51681 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL427488 0.90 FAAH (0.49) NPY5RFAAHCES2ALDH1A1MCHR1
SCHEMBL14950260 0.87 FAAH (0.53) NPY5RFAAHCES2
SCHEMBL427155 0.87 FAAH (0.62) FAAHCES2ALDH1A1CACNA2D1MCHR1
SCHEMBL424687 0.86 FAAH (0.64) FAAHCES2ALDH1A1CACNA2D1MCHR1
SCHEMBL428187 0.86 FAAH (0.49) FAAHCES2CACNA2D1MCHR1HPGDS
SCHEMBL16433293 0.85 FAAH (0.48) NPY5RFAAHCES2ALDH1A1CACNA2D1
SCHEMBL424587 0.84 FAAH (0.62) FAAHCES2ALDH1A1CACNA2D1MCHR1
SCHEMBL427420 0.84 FAAH (0.48) FAAHCES2CACNA2D1MCHR1HPGDS
SCHEMBL425456 0.83 FAAH (0.53) NPY5RFAAHCES2
SCHEMBL14937893 0.83 FAAH (0.52) NPY5RFAAHCES2KMT2ACCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606035-B1 PROCES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA S A (PT) 2017-09-06 — — EP disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 — — US disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 — — US disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 — — US disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 — — US disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 — — US disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS UTS2R, ARG1, PRMT1 NPY5R 100/4885FAAH 2166/4885CES2 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.